Ming-Lung Yu, M.D., Ph.D.

Professor, Faculty of Medicine, College of Medicine,

Kaohsiung Medical University, Kaohsiung, Taiwan

Sex: Male

Nationality Taiwan, Republic of China (R.O.C.)

Address: Hepatobiliary Division, Department of Medicine, Kaohsiung Medical University Hospital, 100 Tzyou 1st Rd, Kaohsiung 807, Taiwan

Tel: (O) 886-7-3121101 Ext 7475 

Fax: (O) 886-7-3123955

E-mail: fish6069@gmail.com; fishya@ms14.hinet.net; d780178@kmu.edu.tw

FACULTY

2000-2003 Assistant Professor, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

2003-2006 Associate Professor, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

2006-now Professor, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan (015247)

EDUCATION

1989     M.D., Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

2000     Ph.D. Graduate Institute of Medical Science, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

POSTDOCTORAL TRAINING

  • 1988-1989   Internship, Kaohsiung Medical University Hospital
  • 1989-1992   Residency training, Department of Medicine, Kaohsiung Medical University Hospital, Taiwan
  • 1992-1994   Chief Resident, Department of Medicine, Kaohsiung Medical University Hospital, Taiwan
  • 1992-1994   Gastroenterology training, Division of Hepatology, Department of Medicine, Kaohsiung Medical University Hospital, Taiwan
  • 1994-1996   Occupational Medicine training, Department of Occupational Medicine, Kaohsiung Medical University Hospital, Taiwan

LICENSURE AND CERTIFICATION

  • 1989     National Medical Board of Republic of China
  • 1992     Board of Internal Medicine, R.O.C. (No. 003370)
  • 1994     Board of Gastroenterology, R.O.C. (No.0550)
  • 2002     Board of Occupational Medicine, R.O.C. (No. 0115)
  • 2002     National Board of Occupational Medicine, R.O.C. (No. 000058)
  • 2007     Clinical Principal Investigator (CPI), Academy of Pharmaceutical Physicians and Investigators

HOSPITAL APPOINTMENTS

  • 1994 -now      Attending Physician, Division of Hepatology, Department of Medicine, Kaohsiung Medical University Hospital
  • 1994 -now      Attending Physician, Department of Preventive Medicine, Kaohsiung Medical University Hospital
  • 1994 -now      Attending Physician, Department of Occupational Medicine, Kaohsiung Medical University Hospital
  • 1998 -2003    Attending Physician, Department of Medicine, Kaohsiung Municipal Hsiao Kang Hospital
  • 1998 -2003    Attending Physician, Department of Occupational Medicine, Kaohsiung Municipal Hsiao Kang Hospital
  • 2010 -2012    Superintendent, Kaohsiung Municipal Ta-Tung Hospital
  • 2012 - now    Vice Superintendent, Kaohsiung Medical University Hospital

OTHER PROFESSIONAL POSITIONS

  • 1996-1998      Member of the Medical Information Technology and Development Committee, Kaohsiung Medical University Hospital
  • 1998-2003      Chief, Department of Occupational Medicine, Kaohsiung Municipal Hsiao Kang Hospital
  • 1998-2002      Member of the Radiation Safety Committee, Kaohsiung Municipal Hsiao Kang Hospital
  • 1999-now       Deputy Secretary General, Taiwan Liver Research Foundation
  • 2001-2002      Director of the Occupational Safety and Health Committee, Kaohsiung Municipal Hsiao Kang Hospital
  • 2003-2005      Member of the Kaohsiung City Committee of Occupational Disease Identification
  • 2003-2009      Secretary of Medical Affairs, Kaohsiung Medical University Hospital
  • 2003-2009      Director, Department of Preventive Medicine, Kaohsiung Medical University Hospital
  • 2007-2009      Professional Consumer of Drug Advisory Committee, Department of Health, Executive Yuan, ROC.
  • 2009-2009      Chairman of preparatory committee, Kaohsiung Municipal Ta-Tung Hospital
  • 2010-2011      Secretary General, Taiwan Association for Study of Liver Disease

AWARDS AND HONORS

  • 1994 Best Chief Resident, Department of Medicine, Kaohsiung Medical University Hospital
  • 2005 Best clinical research article, annual meeting of Society of Internal Medicine, R.O.C., Taipei
  • 2006 Outstanding Research Article Award, Kaohsiung Medical University, 2005
  • 2006 Best Research Performance Index Award, Kaohsiung Medical University, 2005
  • 2007 Outstanding Research Article Award, Kaohsiung Medical University, 2006
  • 2007 Best Research Performance Index Award, Kaohsiung Medical University, 2006
  • 2008 Best Poster Award, 18th Conference of the APASL in Seoul, March 23-26, 2008
  • 2008 Outstanding Research Article Award, Kaohsiung Medical University, 2007
  • 2008 Best Research Performance Index Award, Kaohsiung Medical University, 2007
  • 2009 Outstanding Research Article Award, Kaohsiung Medical University, 2008
  • 2009 Best Research Performance Index Award, Kaohsiung Medical University, 2008
  • 2010 Best Poster Award, 7th Single Topic Conference of the APASL in Chiba, December 17-18, 2010
  • 2010 Best Research Performance Index Award, Kaohsiung Medical University, 2010
  • 2011 Outstanding Research Article Award, Kaohsiung Medical University, 2010
  • 2011 Best Research Performance Index Award, Kaohsiung Medical University
  • 2012 Best Research Article, Taiwan Liver Research Foundation, 2012
  • 2012 Outstanding Research Article Award, Kaohsiung Medical University, 2011
  • 2012 Best Research Performance Index Award, Kaohsiung Medical University, 2011
  • 2012 Kao-Xing Award, Kaohsiung Medical Association
  • 2012 Outstanding Research Award, National Science Council, 2012

MEMBERSHIPS

 

  • 1989 Formosan Medical Association, R.O.C.
  • 1989 Society of Internal Medicine, R.O.C.
  • 1992 Gastroenterological Society of Taiwan (No. 0809)
  • 1994 The Society of Ultrasound in Medicine of the Republic of China (No. 03945)
  • 1994 Environmental and Occupational Medicine Association, R.O.C. (No. 0352)
  • 2002 Taiwan Association for Study on Liver Disease
  • 2006 Asia Pacific Association for the Study of the Liver

MAJOR RESEARCH INTERESTS

 

  1. Molecular epidemiology of hepatitis C virus infection in Taiwan
  2. Quantification of serum hepatitis C virus (HCV) RNA in chronic hepatitis C patients
  3. Treatment of patients with acute and chronic hepatitis C
  4. Molecular epidemiology of GB virus C/hepatitis G virus infection in Taiwan
  5. Natural course of GB virus C/hepatitis G virus infection in different population
  6. GB virus C/hepatitis G virus infection in patients with chronic hepatitis C patients treated with interferon-alpha
  7. Molecular epidemiology of TT virus infection in Taiwan
  8. The effect of mass hepatitis B virus vaccination in Taiwan
  9. Treatment of chronic hepatitis B patients

PRINCIPAL CLINICAL AND HOSPITAL SERVICE RESPONSIBILITIES

 

  • 1994-now Attending Physician, Division of Hepatology, Department of Medicine, Kaohsiung Medical University Hospital
  • 1994-now Attending Physician, Department of Preventive Medicine, Kaohsiung Medical University Hospital
  • 1994-now Attending Physician, Department of Occupational Medicine, Kaohsiung Medical University Hospital
  • 1998-2003 Attending Physician, Department of Medicine, Kaohsiung Municipal Hsiao Kang Hospital
  • 1998-2003 Attending Physician, Department of Occupational Medicine, Kaohsiung Municipal Hsiao Kang Hospital

TEACHING EXPERIENCE

 

  • 1989-now Clinical teaching for medical students at Kaohsiung Medical University Hospital
  • 1992-now Resident Training in Clinical Medicine at Kaohsiung Medical University Hospital
  • 1994-now Hepatology fellow training in Clinical Hepatology at Kaohsiung Medical University Hospital
  • 1998-now Resident Training in Clinical Medicine and Clinical Hepatology at Kaohsiung Municipal Hsiao Kang Hospital
  • 2000-now Hepatology in School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
  • 2009-now Molecular basis of liver disease at Graduate Institute of Clinical Medicine, Kaohsiung Medical University

 

HONORARY EDITORS-IN-CHIEF OF SCIENTIFIC JOURNAL

World Journal of Gastroenterology, 2010-2012

ACADEMIC EDITOR OF SCIENTIFIC JOURNAL

PLOS ONE, since 2012

GEUST EDITOR

Hepatitis Research and Treatment, 2010 

Current Hepatitis Reports, 2013

EDITORIAL BOARD OF SCIENTIFIC JOURNAL

ISNR Hepatology, since 2012

Gastroenterology and Hepatology, since 2011

World Journal of Gastroenterology, 2007-2009

The Open Infectious Diseases Journal, since 2007

ADVISORY EDITORIAL BOARD OF SCIENTIFIC JOURNAL:

The Korean Journal of Hepatology, since 2010

INVITED REVIEWER OF SCIENTIFIC JOURNALS:

The Lancet,

Hepatology,

Gut,

Journal of Hepatology,

Clinical Infectious Disease,

Canadian Medical Association Journal,

Thorax,

Journal of Infectious Disease,

PLoS ONE,

Antiviral Therapy,

Journal of Viral Hepatitis,

Liver International,

Expert Review of Anti-infective Therapy,

Tissue Antigen,

Translational Research,

Journal of Medical Virology,

Journal of Gastroenterology and Hepatology,

Hepatology International,

Transactions of the Royal Society of Tropical Medicine and Hygiene,

World Journal of Gastroenterology,

Digestive Disease and Science,

Journal of Biomedical Science,

Archives of Medical Research,

International Journal of Immunogenetics,

Current Pharmacogenomics,

Cellular & Molecular Immunology,

Nephrology,

Journal Of Formosa Medical Association,

Kaohsiung Journal of Medical Science,

Intervirology,

Archives of Medical Research,

 

INVITED SPEECH IN INTERNATIONAL CONFERENCE

2012

  • HBsAg and dual HBV+HCV infection. International Symposium on HBsAg Quantitation, Keelung, Taiwan, November 24, 2012.
  • Triple therapy and second generation drug. 10th Asian Pacific Association for the Study of the Liver Single Topic Conference, Ulaanbaatar, Mongolia, September 7-9, 2012.
  • The clinical impact of the recent research on hepatitis C: Asian perspective. 6th Ditan International Conference on Infectious Diseases, China National Convention Center, July 12– 15, 2012.
  • In light of new treatment strategies: comparison of APASL, AASLD and EASL guidelines. 2nd Asia Pacific Perspectives in Hepatitis Forum, Chiang Mai, Thailand, 1-2 June 2012.
  • Emerging Paradigms In HCV Management and new Direct-acting Antivirals. Cebu City, Philippines, February 25, 2012
  • Predictors of HCV treatment beyond of IL28B. 22th Congress of the Asian Pacific Association for the Study of the Liver, Taipei, Taiwan, Feburary 16-19, 2012.
  • Optimizing Cure of Chronic Hepatitis C in Asia Pacific. 22th Congress of the Asian Pacific Association for the Study of the Liver, Taipei, Taiwan, Feburary 16-19, 2012.
  • Treatment of an HBV-HCV coinfected patient with Peg-IFN alfa-2a/RBV. 22th Congress of the Asian Pacific Association for the Study of the Liver, Taipei, Taiwan, Feburary 16-19, 2012.

 

 

 

 

Go to top